Stay updated on Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction

Sign up to get notified when there's something new on the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page.
Latest website image capture
Clouds background image

Latest updates to the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision added: v3.5.0; revision v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-18T17:47:19.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Updated revision from v3.4.2 to v3.4.3. The update likely includes minor patches and UI improvements.
    Difference
    0.0%
    Check dated 2026-03-11T17:10:34.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 tag and removed the government funding notice about operations status; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:13:28.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added a site-wide funding notice and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-03T23:53:03.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option on the page. Updated metadata labels to 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-27T22:50:45.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Expanded the study location data with numerous regional and country locations (e.g., California, Florida, Georgia, Kansas, Maryland, New York, North Carolina, Ohio, Texas; New South Wales, Queensland, Victoria, Western Australia; Ontario, Quebec; Chiba, Hokkaido, Ishikawa-ken, Saitama) and removed the HHS Vulnerability Disclosure link. Revision updated to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T02:26:46.000Z thumbnail image

Stay in the know with updates to Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction

Enter your email address, and we'll notify you when there's something new on the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page.